Prima Nexus / Events / 2019

10th ELISA Hands-On Workshop

Prima Nexus ran its 10th ELISA Hands-On Workshop on 19 September 2019 at the Radioisotope Lab of the Faculty of Medicine, Universiti Putra Malaysia (UPM).

· Workshop · Organised by Prima Nexus

Participants and trainers in lab coats stand together for a group photo in the laboratory
Participants of the 10th ELISA Hands-On Workshop, UPM, 19 September 2019.

About the workshop

The workshop was the tenth in Prima Nexus’s series of hands-on ELISA workshops. Postgraduate students and researchers from UPM, UKM, UM, UiTM, UniKL MESTECH, IMU and KPJ Healthcare University College worked through an ELISA at the bench, from preparing the samples to reading the plate.

Prima Nexus’s part

Prima Nexus organised and ran the workshop. For Prima Nexus’s immunoassay services, see the ELISA and Luminex page.

More of our work with UPM.

Read the story: Prima Nexus ran four hands-on ELISA workshops and a cell culture workshop at Universiti Putra Malaysia in 2019.

About Prima Nexus

Founded in 2014, Prima Nexus Sdn Bhd is a Malaysian research, scientific consulting and integrated research support company advancing scientific discovery and healthcare innovation. We provide end-to-end research solutions, from early-stage discovery and experimental design to cell-based studies, preclinical animal testing, clinical trials and commercialization. Our multidisciplinary expertise spans genomics, genetic applications, proteomics, molecular biology, stem cell research, bioinformatics and clinical research. Through strategic collaborations with universities, research institutions, industry and global technology partners, we connect scientific expertise and advanced technologies to accelerate research into real-world applications. We also run hands-on training for researchers across Malaysia. More about Prima Nexus.

ELISA

Work with us

Planning a workshop, a study or a lab set-up? Talk to us.

We run hands-on training at universities and institutes across Malaysia, and support research teams from a single biomarker panel to a multi-site clinical programme.